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Establishing the correct diagnosis in newborns presenting with blisters and erosions is not always a straightforward process. Many
diﬀerent disease entities including acquired (i.e., infectious, immunobullous, traumatic) and inherited disorders have to be taken
intoconsideration.Similarities in clinical appearance, colonization and/orsuperinfections ofpreexisting skinlesions,as well as the
absence of late changes in the neonate often pose signiﬁcant diagnostic challenges. In this paper we discuss by giving examples the
process of making an accurate diagnosis of blistering skin diseases in the neonatal period on the basis of a diagnostic algorithm. In
addition, we provide an overview of the rational use and the limitations of laboratory procedures such as microbial testing, routine
light microscopy, immunoﬂuorescence antigen mapping, transmission electron microscopy, and molecular genetic analysis.
Copyright © 2009 Elke Nischler et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Neonatal skin diﬀers in structure and function from adult
skin, and hence the dermatoses seen during this period
diﬀer in their clinical presentation. Newborns are more
likely to develop blisters and erosions in response to heat,
chemical irritants, and mechanical trauma and are at an
increased risk for cutaneous infections [1]. In addition,
most hereditary disorders with increased skin fragility may
occur ﬁrst during the neonatal period. Thus, the spectrum
of potential diﬀerential diagnoses is extensive and ranges
from more transient benign to mutilating or potentially life-
threatening blistering conditions (Table 1). The distinction
between diﬀerent entities within the ﬁrst weeks of life is
crucial for the further management and the prognosis of the
neonate.
In this article we describe common problems (Table 2)
in the diagnostic routine on the basis of a report on four
selected patients. We recommend emphasizing an algorith-
mic approach in the diagnostic work up (Figure 1). That
includes a detailed medical history (family, maternal, and
obstetrical), followed by a complete physical examination
(head to toe) and, if needed, an appropriate diagnostic rou-
tine such as microbial testing, skin biopsies for histological
andultrastructuralassessment,andmoleculargenetictesting
in case of hereditary skin diseases.
2.CaseReports
2.1. Patient 1—Dominant Dystrophic Epidermolysis Bullosa.
The history of a two-year-old boy revealed that he was born
withanextensiveskinerosioninvolvingthelowerleftlegand
the dorsum of the left foot (Figure 2(a)). The denuded area
reepithelized completely within 3 weeks. Subsequently, small
blisters on mechanically strained areas (i.e., hands, knees,
and feet) appeared. On clinical examination the two-year-
old boy was in good health and presented with tiny erosions
on hands and knees, an erythematous plaque with some
milia on the left knee, and toenail dystrophy (Figure 2(c)).
The lower left leg showed an atrophic scar in the area of
the previous erosion (Figure 2(b)). A small, inconspicuous
naevus was found above this area. There was a family history
of ﬁnger- and toenail dystrophy in his mother, maternal
aunt and uncle, maternal grandmother and grand aunt,2 Dermatology Research and Practice
Table 1: Diﬀerential diagnosis of erosions and blisters in the neonate and young child
∗.
Inherited or congenital disorders Acquired disorders
Epidermolysis bullosa hereditaria—all types (simplex, junctional,
dystrophic)
Immunobullous disorders
Ichthyosis bullosa of Siemens Epidermolysis bullosa acquisita
Netherton syndrome Linear IgA dermatosis
Congenital peeling skin syndromes Bullous pemphigoid
Pachyonychia congenita Cicatricial pemphigoid
Kindler’s syndrome Pemphigus
Congenital porphyria Infectious diseases
Acrodermatitis enteropathica Herpes simplex
Incontinentia pigmenti Bullous impetigo
Ectodermal dysplasia Staphylococcal scalded skin syndrome
AEC syndrome (Hay-Wells syndrome) Congenital lues (pemphigus syphiliticus)
Ectodermal dysplasia with plakophilin 1 deﬁciency Other bacterial, viral or fungal infections
Congenital absence of skin (cutis aplasia) Other diseases or conditions
Congenital erosive dermatosis with reticulate supple scarring Bullous mastocytosis
Mendes da Costa syndrome Behcet disease
Shabbir’s syndrome (laryngo-onychocutaneous syndrome) Traumatic blisters (sucking, other)
Epidermolytic hyperkeratosis (bullous ichthyosiform erythroderma) Toxic epidermal necrolysis
∗Modiﬁed by Eady et al. [2].
Table 2: Variables causing problems in diﬀerential diagnosis.
Clinical features
Similarity and overlapping of clinical features
Coexistance of diﬀerent diseases
Colonization and/or superinfection
Absence of late changes in the neonate (scar formation, pigmentation changes, nail dystrophy)
Diagnostical methods
Sample (site of sample not representative, secondary alterations)
Timepoint of sample collection (i.e., higher herpes simplex virus load in early vesicles)
Sensitivity and speciﬁty of method
Technical problems (wrong transportation media, ...)
Experience in interpreting the results
and maternal great grandmother (Figure 3). Besides nail
dystrophy the grandmother also showed localized blistering
in the pretibial area and the patients mother reported
of a period in childhood with mild pretibial blistering.
A perilesional skin biopsy of the grandmother, sent to
us for immunoﬂuorescence (IF) antigen mapping, showed
normal expression patterns of keratin 1, 5, 8, 10, and 14,
plectin, bullous pemphigoid antigen-1 (BPAG1) and bullous
pemphigoid antigen-2 (BPAG2, also called collagen type
XVII collagen), integrins α6a n dβ4, laminin 332, and
collagen types IV and VII. So far the boy himself was not
available for a skin biopsy. Based on the clinical presentation
and the family history the diagnosis of dominant dystrophic
epidermolysis bullosa (EB) was considered. Mutation detec-
tion and screening of the 118 exons of COL7A1 of the index
patient was performed using the “priority strategy” and
ﬁnally conﬁrmed the diagnosis. We could disclose a hitherto
unpublished heterozygous mutation deﬁned as transition of
G to A at position 7120G > A in exon 93. At the amino acid
level this mutation was identiﬁed as G2374R. Consequently
all available samples of the family members were sequenced
forward for this mutation and conﬁrmed reverse on the
genetic analyzer ABI 3130 (Figure 4).
Interestingly, the mutation was found in all phenotypes
of the disease varying among the aﬀected family members
covering blisters and nail dystrophy presented by the index
patient and his grandmother. In contrast, his mother had
blisters merely in childhood, while many other examined
family members showed solely nail dystrophy (Figure 3).
To exclude a possible single nucleotide polymorphism
(SNP) we screened 52 wildtype DNA samples for this locus
and could conﬁrm only wildtype alleles (not shown). A
hithertounpublished heterozygous single nucleotide poly-
morphism 7006G > T; G2336W was also detected in most
of the samples of this family and in one of the screened 50













































Figure 2: (a) Extensive denuded area enclosing the heel, ankle,
joint, and dorsum of the left foot shortly after birth. (b) The same
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Nail dystrophy + blisters
Figure 3: Segregation of the mutation 7120G > A: G2374R and
its phenotypic features are shown in the pedigree of the family.
The index patient (IV-1) and his grandmother (II-3) show blisters
a n dn a i ld y s t r o p h y .H i sm o t h e r( I I I - 4 )p r e s e n t e dw i t hb l i s t e r s
solely in childhood and appears with nail dystrophy. All other
family members carrying this mutation present with nail dystrophy
without blisters.4 Dermatology Research and Practice
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Figure 4: Detection of mutation 7120G > A; G2374R in COL7A1 by sequence analysis in selected family members, except sample III-3,
which is wildtype for this locus.
2.2. Patient 2—Bullous Impetigo. A one-day-old, afebril
boy was admitted to the neonatal in-patient unit of our
hospital. He was born in the fortieth week of gestation after
an uneventful pregnancy. Physical ﬁndings on admission
included pustules and erosions of 1 to 5 cm diameter
aﬀecting the feet, the right hand, and the neck (Figures
6(a) and 6(b)). There was no involvement of mucous
membranes and the family history did not reveal any
bullous skin disorder. Based on the clinical picture the
diagnosis of a bullous impetigo was suspected, even though
a gram stain of blister ﬂuid was not conclusive. Under
systemic antibiotic treatment (augmentin 60mg/kg body-
weight(BW)/day and netilmicin 6mg/kg BW/day) marked
improvement was observed within 24 hours, with complete
healing of the skin lesions by day 7. The subsequent
course of the disease (no new blisters occurred) and a
positive culture of coagulase positive staphylococcus aureus
from a skin swab conﬁrmed the diagnosis of a bullous
impetigo.
2.3. Patient 3—Epidermolysis Bullosa Simplex. Af o u r -
months-old girl was referred to the eb-house Austria for
evaluation of a blistering skin disorder. She was the oﬀspring
ofnonconsanguineoushealthyparentsandhadoneoldersis-
ter who was clinically unaﬀected. Maternal history revealed
recurrent vaginal candida infections during pregnancy. Six
daysafterbirthsub-andperiungualhaemorrhagicblisterson
ﬁngers as well as erosions on oral and anal mucosa occurred.
Initial and subsequent swabs from the skin and oral mucosa
isolated coagulase positive staphylococcus aureus and can-
dida albicans, respectively. Thus the diagnosis of a recurrent
bullous impetigo and a soor stomatitis was suspected. Sys-
temic antibiotic (ceftriaxone 50mg/kg BW/day) and topical
antifungal (miconazol nitrate 2% ointment) treatment ini-
tially improved the skin and mucous membrane condition,
but acral blistering continued to develop (Figure 7(a)). At
4 months of age a skin biopsy of perilesional skin was
obtained. Light microscopy studies revealed cytolysis within
the epidermal basal cell layer indicating an intrastratumDermatology Research and Practice 5
T G CCA K GGCC T G CCA K GGCC
T G CC A K GGCC T G CCA K GGCC















Figure 5: Detection of SNP 7006G > A; G2336W in COL7A1 by sequence analysis in selected family members, except sample III-3, which is
wildtype for this locus.
(a) (b)
Figure 6: (a) and (b) patient 2: Partially ruptured pustules, resulting in large circumscribed erosions on the right hand and left foot.6 Dermatology Research and Practice
(a) (b)
Figure 7: (a) Patient 3: haemorrhagic blister on the left little toe. (b) Histology of perilesional skin shows basal cell cytolysis (arrows)
(Hematoxylin-eosin stain; original magniﬁcation: X100).
basale split formation (Figure 7(b)). IF antigen mapping
conﬁrmed that the level of split formation was through the
basalcelllayerbutshowednormalexpressionofallexamined
basement membrane proteins (i.e., keratin 1, 5, 8, 10, and
14, plectin, BPAG1 and 2, integrins α6a n dβ4, laminin 332,
and collagen types IV and VII). The clinical presentation and
the detection of an intra-stratum basale split formation led
to the diagnosis of an EB simplex. A follow-up examination
at 13 months of age revealed small blisters at friction points
(i.e.,perianal,armpits) and onthepalms thathealedwithout
scarring.
For mutation analysis we screened the genes KRT5
(keratin 5) and KRT14 (keratin 14). To get rid of the
pseudogenes in KRT14 a digest of all exons prior to PCR
was performed [3]. By sequencing we could identify a well-
known [4] and in our case spontaneously arising mutation
in KRT14 designated as 374G > A and R125H while the
parentswerenocarriersofthismutation(Figure8).Stephens
et al. [5] had identiﬁed codon R125H substitutions in three
unrelated sporadic EBS-DM patients which were not found
in their clinically unaﬀected parents. Further de novo cases
were published by Shemanko et al. and M¨ uller et al. [6, 7].
This codon is the most commonly aﬀected in all keratin
disorders and reﬂects high mutability. The fact of sporadic
arisingmutationshasthereforeimplicationsinfuturegenetic
counseling for this family.
2.4. Case 4—Recessive Dystrophic Epidermolysis Bullosa. A
girl was born at the thirty-ninth week of gestation with a
localized area of absent skin on the right leg and the left sole
(demonstrated via teledermatology) (Figure 9(a)). Addition-
ally,asubungualhaematomaontherightthumbwaspresent.
The girl’s older sister was born with a malformation of the
cerebellum, but there was no family history for a blistering
skin disorder. At one week of age a perilesional skin biopsy
was obtained and sent to the eb-house Austria in Michel’s
transport media [8]. Light microscopy studies of a cryostat
section revealed a subepidermal blister formation. IF antigen
mapping on perilesional skin showed a positive staining for
BPAG1 on the blister roof and for laminin 332 and type IV
collagen on the roof and the ﬂoor of the split. Interestingly,
two major basement membrane proteins, that is, BPAG2
and collagen type VII were absent (Figures 9(c) and 9(d)).
A subsequent IF antigen mapping on clinically unaﬀected
skin (inner aspect upper arm) demonstrated bright linear
staining of BPAG2 and collagen type VII on the roof of
the blister, indicating a dystrophic cleavage (Figures 9(e)
and 9(f)). The large skin defects of the lower extremities
healed within 6 weeks with atrophic scarring (Figure 9(b)).
Subsequently, small blisters appeared in the scar area and
on mechanically strained skin and mucosa (i.e., hands, feet,
oral and genital mucosa). Additionally, moderate ﬁnger- and
toenail dystrophy was observed.
Mutation detection and screening of the 118 exons of
COL7A1 gene of the index patient was performed using
the “priority strategy.” A novel splice site mutation could
be detected in the region of intron 28/exon 29 located as
3760-1G > A in a homozygous status in the patient and was
conﬁrmed as heterozygous status in the parents (Figure 10).
The mutation is supposed to completely destroy the acceptor
splice site. All sequence analyses were done forward and
reverse. As we had nonconcordant antigen mapping results
for COL7A1 and COL17A1 in two diﬀerent punch biopsies,
we examined DNA of these biopsies for the existence of
the splice mutation in COL7A1. The mutation was found
homozygous, as expected, in DNA of the ﬁrst punch biopsy
withCOL7A1negativeIF,butunexpectedly,itwasalsofound
inDNAofthesecondpunchbiopsywithCOL7A1positiveIF.
Further, we screened DNA of the ﬁrst punch biopsy, which
was negative in IF to antibodies against COL17A1, for all
COL17A1 exons but we could not disclose any mutation in
this gene.
3. Discussion
3.1. Exact Medical History and Clinical Examination. A
detailed family, maternal, and obstetrical history can provide
important clues on the nature of the lesions [9]. For
example, a maternal history of genital herpes or vaginal yeast
infections during pregnancy could point to an infectious
etiology (see patient 3) whereas a family history of chronic
blistering suggests the diagnosis of a hereditary condition.Dermatology Research and Practice 7
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Figure 8: Sequence analysis of 374G > A; R125H in KRT14. The
patient is a heterozygous carrier for this de novo mutation, whereas
the parental alleles reﬂect wildtype status.
Conversely, skin fragility or trauma-induced blisters may
be a minor or even nonexistent feature in some subtypes
of EB (i.e., dominant dystrophic EB) [10]. The family
history of patient 1 demonstrates that only the patient, his
grandmother, and his mother (exclusively in childhood)
showed localized blistering and milia formation in addition
to nail dystrophy, whereas in other aﬀected family members
nail dystrophy was the only sign of dominant dystrophic EB.
Therefore a comprehensive skin examination that includes
checking of mucous membranes, hair, and nails should be
performed on all family members, not to overlook helpful
hints for establishing the correct diagnosis.
3.2. Cutaneous Infections. The epidermis, when mature,
provides an important barrier against invasion by microor-
ganisms. The maturation (i.e., keratinization) of fetal skin is
functionally incomplete at birth and continues over the ﬁrst
few weeks of life [11]. Thus, all neonates are at an increased




Figure 9: (a) Patient 4: shortly after birth, a large denuded area
was found on the left leg. (b) The same leg four weeks later
showing healing and scar formation. (c)-(d) IF antigen mapping
of perilesional skin: absence of BPAG2 (c) and collagen type VII
(d). (e)-(f) IF antigen mapping of clinically unaﬀected skin (inner
aspect upper arm): positive staining for collagen type XVII (e) and
collagen type VII (f) ((c)–(f) original magniﬁcation: X400).
blisters and/or erosions. Moreover, many infectious agents
(i.e., staphylococcus aureus, pseudomonas aeruginosa, and
candida species) frequently colonize, and/or superinfect
existing erosions and often complicate the diagnostic routine
by hiding the underlying pathomechanism [12]. Our ﬁnd-
ings in patient 3 illustrate this important point. As EB and
bullous impetigo lesions can be very similar in appearance,
cliniciansshouldbeawarethatEBlesionscouldbecoinfected
with coagulase positive staphylococcus aureus and take the
p r o p e rs t e p st os c r e e nf o ri t sp r e s e n c e .
Simple and rapid clinical laboratory tests in the initial
work-up for infections are Gram- and Giemsa-stained
smears (optimally, ﬂuid from an intact blister/vesicle) and
direct microscopy with 10% potassium hydroxide (KOH)
preparations [9, 13]. These tests often provide useful infor-













Figure 10: Sequence analysis of 3760-1G > A in COL7A1. The
patientishomozygous forthismutation, andparental heterozygous
alleles conﬁrm the genetic transmission.
However, patient 2 demonstrates that the Gram stain,
like other laboratory tests, has certain inherent limitations
and is subject to technical variation and misinterpretation
[14]. Therefore, if the initial evaluation does not yield the
diagnosis, but an infectious etiology or superinfection is
strongly suspected, an appropriate antimicrobial therapy
should be introduced and eventually changed depend-
ing on the results of conﬁrmatory tests such as bacte-
rial, fungal, and viral cultures, serology, and PCR. The
prompt recognition and appropriate treatment of cutaneous
infectious diseases in neonates is essential to shorten the
course of the disease as well as to prevent widespread
dissemination, particularly in patients with a disrupted
skin barrier. Moreover for contagious skin diseases such
as bullous impetigo appropriate hygienic measures are
important to prevent spread to others. If skin lesions do
not clear under appropriate antimicrobial treatment and/or
new blisters continue to develop, a skin biopsy should be
taken.
3.3. The Skin Biopsy as Standard for Diagnosis. Although
it is an invasive procedure, one should not hesitate with
the decision for a skin biopsy on neonates. Histological
and ultrastructural assessment of skin samples can often
facilitate and accelerate the proof or exclusion of various
diﬀerential diagnoses [15]. If a hereditary cause is suspected,
the biopsy should be taken from clinically normal appearing
skin. It may be helpful to induce a blister by slightly
rotating a pencil eraser at the site of the biopsy [16]. The
purpose of taking a biopsy from clinically normal skin is
to avoid the appearance of secondary changes. For example,
subepidermal blisters may appear to be intraepidermal if
regeneration of new epithelium occurs in an older lesion
[17]. Additionally, older lesions that contain necrotic tissue
tend to accumulate neutrophils and proteolytic degradation
of basement antigens can inﬂuence the outcome of IF
examinations [18].
Patient 4 with recessive dystrophic EB illustrates this
important point. While IF analysis of perilesional skin
revealed absence of collagen type VII and BPAG2,b o t h
proteins could be detected in unaﬀected skin. These ﬁndings
suggest a proteolytic degradation of both proteins in perile-
sional/lesional skin.
Routine Light Microscopy. Allows the pathologist to identify
the anatomical level of the split (i.e., subcorneal, suprabasal,
“subepidermal”) and the nature of the inﬂammatory inﬁl-
trate in the dermis or within the blister [19]. For example,
histologic features of the blisters in bullous impetigo include
loss of cell adhesion in the superﬁcial epidermis, just below
the stratum corneum and an inﬂammatory inﬁltrate, mostly
consisting of neutrophils, whereas inherited EB usually
presents as subepidermal bullae without inﬂammatory cells
[20, 21]. However, in some cases of mainly newborn EB
patients there is a predominantly eosinophilic inﬁltrate [22].
The appearance of a signiﬁcant number of eosinophils
associated with a subepidermal blister formation might
suggest blistering diseases caused by immunologically medi-
ated cleavage such as bullous pemphigoid or linear IgA
dermatosis. These autoimmune blistering diseases can be
ruled out by direct IF examinations that detect immune
deposits in the epidermal basement membrane zone. Rou-
tine light microscopy is generally not very helpful in delin-
eating a speciﬁc subtype of EB, since both junctional and
dystrophic subtypes represent with “subepidermal” splits
[2, 23]. Therefore precise classiﬁcation of individual patients
with EB requires determination of the level of tissue sepa-
ration by IF antigen mapping and/or transmission electron
microscopy.
Immunoﬂuorescence Antigen Mapping and/or Transmission
Electron Microscopy (TEM). IF antigen mapping is a mod-
iﬁed IF technique whereby the ultrastructural level of skin
cleavage can be deduced by determination of the localization
(i.e., roof versus ﬂoor of an induced blister) of binding
within an EB skin specimen of a series of antibodies having
known ultrastructural binding sites [24, 25]. For example,
anti-BPAG2 (type XVII collagen) antibody can be used to
stainthelowersurfaceofbasalkeratinocytes,andantitype IVDermatology Research and Practice 9
collagen antibodies will stain the lamina densa [2, 24–26]. In
the simplex variants of EB with an intraepidermal separation
at the level of basal cells all antibodies will stain the ﬂoor
of the split. In junctional types of EB the separation occurs
within the lamina lucida and therefore antibodies against
BPAG2 will bind on the roof of the blister whereas antitype
IV collagen antibodies stain the ﬂoor. In dystrophic forms of
EB,wheretheseparationoccursbeneaththelaminadensa,all
antibodies will stain the roof of the split [2, 27]. Additional
studies with a selected series of antibodies (i.e., in addition
to the above mentioned, keratin 5 and 14, plectin, integrins
α6a n dβ4, laminin 332, BPAG2, and type VII collagen) may
reveal defective or the lack of proteins and therefore may
provide clues concerning the genetic origin [23, 28]. Besides
IF antigen mapping, TEM is another major diagnostic
technique for the diagnosis of EB. The primary advantage
that TEM has over IF antigen mapping is that it is the only
technique whereby associated ultrastructural ﬁndings can be
directlyassessedandquantiﬁed[15].Morespeciﬁcally,direct
assessment of possible morphologic or morphometric alter-
ations of some cellular or basement membrane-associated
structures (i.e., hemidesmosomes with subbasal dense plates,
anchoring ﬁlaments or ﬁbrils, and tonoﬁlaments) may be
of diagnostic importance for speciﬁc subtypes of EB [29,
30]. However, TEM is a relatively expensive and time
consuming technique and the accurate interpretation of the
above described studies demands considerable experience
on the part of the pathologist. Whereas TEM and IF
antigen mappings were thought to have equal sensitivity and
speciﬁcity, a recent comparative study between these two
techniques demonstrated that IF antigen mapping may be
a more accurate diagnostic test for the major types of EB
[31].
3.4. Molecular Genetic Testing. T h ei m p o r t a n c eo fa na c c u -
rate moleculardiagnosis forpatients with heritable blistering
diseases should not be underestimated since it allows better
prognostication regarding the severity and prediction of the
progress of the disease [32]. Moreover the identiﬁcation of
speciﬁc mutations has profound implications for genetic
counseling of families at risk for recurrence of the disease
in the same and subsequent generations. An example is
provided by our patient 4 with a relatively mild dystrophic
formofEB andno familyhistory. Theclinical manifestations
could result either from a de novo dominant mutation
(dominant dystrophic EB) in one of the COL7A1 allels
or from a recessive mutation (recessive dystrophic EB) in
both COL7A1 allels [33]. These two possibilities are only
distinguishable by mutation analysis [34]. In our patient
identiﬁcation of 2 mutant alleles in the proband’s DNA
and demonstration of their inheritance from the respective
parents led to the diagnosis of a recessive dystrophic EB.
Further implications are that the risk of our patient having
an aﬀected oﬀspring is very low owing to relatively low
carrier frequency of the corresponding gene mutations
in the general population, while the risk for the parents
of having another aﬀected oﬀspring is 1 in 4, or 25%
[34, 35].
Furthermore, molecular testing is the basis for future
development of gene therapy and other novel treatment
modalities. However, considering the expense and labor-
intensivenessofthisapproach,moleculartestingstillremains
primarily a research tool for the postnatal diagnosis. The
impact of molecular genetics is the most evident in prenatal
testing, that has proved to be of great beneﬁt for couples
in which one or both partners are patients, or couples who
have already had one aﬀected pregnancy [36]. An extension
of prenatal testing is the development of preimplantation
genetic diagnosis, a technique licensed for severe forms of EB
[36].
4. Conclusion
Our observations highlight simple pitfalls in establishing a
correctdiagnosisofblisteringskindiseasesinnewborns.Dis-
cordance among diﬀerent assessments and clinical ﬁndings
should prompt reassessment of the diagnosis in search of
potential pitfalls. In confusing situations, or when heredi-
tary or immunobullous causes are considered, we suggest
referring the neonates to a center such as the eb-house
Austriathatspecializesinbullousskindiseases.Askinbiopsy
within the ﬁrst week of life and subsequent histopathologi-
cal, immunohistochemical, and ultrastructural analysis can
narrow the spectrum of potential diﬀerential diagnoses. In
case of hereditary skin diseases detection of gene mutations
can conﬁrm the clinically and microscopically suspected
diagnosis and is the basis for genetic counseling and prenatal
diagnosis.
Abbreviations(in alphabeticalorder)
BPAG: Bullous pemphigoid antigen
DIF: Direct immunoﬂuorescence
EB: Epidermolysis bullosa







PCR: Polymerase chain reaction
SNP: Single nucleotide polymorphism
TEM: Transmission electron microscopy.
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